Matches in SemOpenAlex for { <https://semopenalex.org/work/W2319546094> ?p ?o ?g. }
- W2319546094 endingPage "577" @default.
- W2319546094 startingPage "567" @default.
- W2319546094 abstract "Simultaneous inactivation of p53 and hyperactivation of nuclear factor-κB (NF-κB) is a common occurrence in human cancer. Currently, antitumor agents are being designed to selectively activate p53 or inhibit NF-κB. However, there is no concerted effort yet to deliberately design inhibitors that can simultaneously do both. This paper provided a proof-of-concept study that p53–MDM2 interaction and NF-κB pathway can be simultaneously targeted by a small-molecule inhibitor. A series of pyrrolo[3,4-c]pyrazole derivatives were rationally designed and synthesized as the first-in-class inhibitors of p53–MDM2 interaction and NF-κB pathway. Most of the compounds were identified to possess nanomolar p53–MDM2 inhibitory activity. Compounds 5q and 5s suppressed NF-κB activation through inhibition of IκBα phosphorylation and elevation of the cytoplasmic levels of p65 and phosphorylated IKKα/β. Biochemical assay for the kinases also supported the fact that pyrrolo[3,4-c]pyrazole compounds directly targeted the NF-κB pathway. In addition, four compounds (5j, 5q, 5s, and 5u) effectively inhibited tumor growth in the A549 xenograft model. Further pharmacokinetic study revealed that compound 5q exhibited excellent oral bioavailability (72.9%)." @default.
- W2319546094 created "2016-06-24" @default.
- W2319546094 creator A5001185510 @default.
- W2319546094 creator A5001631388 @default.
- W2319546094 creator A5005969908 @default.
- W2319546094 creator A5049872559 @default.
- W2319546094 creator A5056950634 @default.
- W2319546094 creator A5057853505 @default.
- W2319546094 creator A5073005690 @default.
- W2319546094 creator A5086532638 @default.
- W2319546094 date "2014-01-24" @default.
- W2319546094 modified "2023-10-04" @default.
- W2319546094 title "Double-Edged Swords as Cancer Therapeutics: Novel, Orally Active, Small Molecules Simultaneously Inhibit p53–MDM2 Interaction and the NF-κB Pathway" @default.
- W2319546094 cites W1522455546 @default.
- W2319546094 cites W1529921298 @default.
- W2319546094 cites W1650797637 @default.
- W2319546094 cites W1964603185 @default.
- W2319546094 cites W1965214776 @default.
- W2319546094 cites W1967725310 @default.
- W2319546094 cites W1976382352 @default.
- W2319546094 cites W1977348907 @default.
- W2319546094 cites W1991494214 @default.
- W2319546094 cites W1998253936 @default.
- W2319546094 cites W2003971548 @default.
- W2319546094 cites W2004870453 @default.
- W2319546094 cites W2009299673 @default.
- W2319546094 cites W2013791219 @default.
- W2319546094 cites W2023724309 @default.
- W2319546094 cites W2024918098 @default.
- W2319546094 cites W2025476423 @default.
- W2319546094 cites W2031019010 @default.
- W2319546094 cites W2034717859 @default.
- W2319546094 cites W2041323129 @default.
- W2319546094 cites W2050537958 @default.
- W2319546094 cites W2054074966 @default.
- W2319546094 cites W2058445799 @default.
- W2319546094 cites W2060818930 @default.
- W2319546094 cites W2066303715 @default.
- W2319546094 cites W2068039003 @default.
- W2319546094 cites W2068854551 @default.
- W2319546094 cites W2081184407 @default.
- W2319546094 cites W2091089099 @default.
- W2319546094 cites W2093775600 @default.
- W2319546094 cites W2097616194 @default.
- W2319546094 cites W2097933346 @default.
- W2319546094 cites W2099293745 @default.
- W2319546094 cites W2110947069 @default.
- W2319546094 cites W2116416768 @default.
- W2319546094 cites W2133959309 @default.
- W2319546094 cites W2139319526 @default.
- W2319546094 cites W2140595402 @default.
- W2319546094 cites W2142384246 @default.
- W2319546094 cites W2155782154 @default.
- W2319546094 cites W2157640845 @default.
- W2319546094 cites W2158722505 @default.
- W2319546094 cites W2166269098 @default.
- W2319546094 cites W2168059640 @default.
- W2319546094 cites W2999065750 @default.
- W2319546094 cites W4379365691 @default.
- W2319546094 doi "https://doi.org/10.1021/jm401800k" @default.
- W2319546094 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24428757" @default.
- W2319546094 hasPublicationYear "2014" @default.
- W2319546094 type Work @default.
- W2319546094 sameAs 2319546094 @default.
- W2319546094 citedByCount "42" @default.
- W2319546094 countsByYear W23195460942014 @default.
- W2319546094 countsByYear W23195460942015 @default.
- W2319546094 countsByYear W23195460942016 @default.
- W2319546094 countsByYear W23195460942017 @default.
- W2319546094 countsByYear W23195460942018 @default.
- W2319546094 countsByYear W23195460942019 @default.
- W2319546094 countsByYear W23195460942020 @default.
- W2319546094 countsByYear W23195460942021 @default.
- W2319546094 countsByYear W23195460942022 @default.
- W2319546094 countsByYear W23195460942023 @default.
- W2319546094 crossrefType "journal-article" @default.
- W2319546094 hasAuthorship W2319546094A5001185510 @default.
- W2319546094 hasAuthorship W2319546094A5001631388 @default.
- W2319546094 hasAuthorship W2319546094A5005969908 @default.
- W2319546094 hasAuthorship W2319546094A5049872559 @default.
- W2319546094 hasAuthorship W2319546094A5056950634 @default.
- W2319546094 hasAuthorship W2319546094A5057853505 @default.
- W2319546094 hasAuthorship W2319546094A5073005690 @default.
- W2319546094 hasAuthorship W2319546094A5086532638 @default.
- W2319546094 hasConcept C100175707 @default.
- W2319546094 hasConcept C104317684 @default.
- W2319546094 hasConcept C11960822 @default.
- W2319546094 hasConcept C161624437 @default.
- W2319546094 hasConcept C184235292 @default.
- W2319546094 hasConcept C185592680 @default.
- W2319546094 hasConcept C190283241 @default.
- W2319546094 hasConcept C193042331 @default.
- W2319546094 hasConcept C202751555 @default.
- W2319546094 hasConcept C2776192174 @default.
- W2319546094 hasConcept C2777682936 @default.
- W2319546094 hasConcept C2777730290 @default.
- W2319546094 hasConcept C2779730028 @default.
- W2319546094 hasConcept C502942594 @default.